Close Menu

NEW YORK (GenomeWeb) – Weill Cornell Medicine announced today that it has received a $5 million gift to launch a new initiative that will accelerate and expand its use of precision medicine in patient care.

The gift was made by investment firm WorldQuant and its founder Igor Tulchinsky to support the creation of the WorldQuant Initiative for Quantitative Prediction, which aims to develop and use predictive tools and quantitative methods to better understand the genetic factors that drive disease in individual patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.